Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-335021
Filing Date
2012-08-03
Accepted
2012-08-03 16:50:14
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d347120d10q.htm 10-Q 680016
2 EX-31.1 d347120dex311.htm EX-31.1 7927
3 EX-31.2 d347120dex312.htm EX-31.2 8146
4 EX-32 d347120dex32.htm EX-32 5220
  Complete submission text file 0001193125-12-335021.txt   4493059

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cadx-20120630.xml EX-101.INS 595857
6 XBRL TAXONOMY EXTENSION SCHEMA cadx-20120630.xsd EX-101.SCH 50135
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cadx-20120630_cal.xml EX-101.CAL 57243
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cadx-20120630_def.xml EX-101.DEF 98101
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cadx-20120630_lab.xml EX-101.LAB 332197
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cadx-20120630_pre.xml EX-101.PRE 228560
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33103 | Film No.: 121007346
SIC: 2834 Pharmaceutical Preparations